These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30745564)

  • 21. Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain.
    Zhang Y; Liu F; Xiao H; Yao X; Li G; Choi SR; Ploessl K; Zha Z; Zhu L; Kung HF
    Nucl Med Biol; 2018 Nov; 66():1-9. PubMed ID: 30096380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-step preparation of [(18)F]FPBM for PET imaging of serotonin transporter (SERT) in the brain.
    Qiao H; Zhang Y; Wu Z; Zhu L; Choi SR; Ploessl K; Kung HF
    Nucl Med Biol; 2016 Aug; 43(8):470-7. PubMed ID: 27236282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
    Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flotillin-1 interacts with the serotonin transporter and modulates chronic corticosterone response.
    Reisinger SN; Kong E; Molz B; Humberg T; Sideromenos S; Cicvaric A; Steinkellner T; Yang JW; Cabatic M; Monje FJ; Sitte HH; Nichols BJ; Pollak DD
    Genes Brain Behav; 2019 Feb; 18(2):e12482. PubMed ID: 29667320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.
    Huang Y; Hwang DR; Narendran R; Sudo Y; Chatterjee R; Bae SA; Mawlawi O; Kegeles LS; Wilson AA; Kung HF; Laruelle M
    J Cereb Blood Flow Metab; 2002 Nov; 22(11):1377-98. PubMed ID: 12439295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter - A longitudinal combined
    Mc Mahon B; Nørgaard M; Svarer C; Andersen SB; Madsen MK; Baaré WFC; Madsen J; Frokjaer VG; Knudsen GM
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1151-1160. PubMed ID: 30077433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
    Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
    J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.
    Frankle WG; Slifstein M; Gunn RN; Huang Y; Hwang DR; Darr EA; Narendran R; Abi-Dargham A; Laruelle M
    J Nucl Med; 2006 May; 47(5):815-26. PubMed ID: 16644752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered serotonin transporter availability in patients with multiple sclerosis.
    Hesse S; Moeller F; Petroff D; Lobsien D; Luthardt J; Regenthal R; Becker GA; Patt M; Thomae E; Seese A; Meyer PM; Bergh FT; Sabri O
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):827-35. PubMed ID: 24562640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.
    Milak MS; Ogden RT; Vinocur DN; Van Heertum RL; Cooper TB; Mann JJ; Parsey RV
    Biol Psychiatry; 2005 Jan; 57(1):102-6. PubMed ID: 15607307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.
    Park HS; Jung IS; Lim NH; Sung JH; Lee S; Moon BS; Lee BC; Kang KK; Kim SE
    Urology; 2014 Jul; 84(1):245.e1-7. PubMed ID: 24824409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.
    Yamamoto S; Ohba H; Nishiyama S; Harada N; Kakiuchi T; Tsukada H; Domino EF
    Neuropsychopharmacology; 2013 Dec; 38(13):2666-74. PubMed ID: 23880871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Joo YH; Kim YB; Cho ZH
    Brain Res; 2015 Dec; 1629():63-71. PubMed ID: 26459992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.